BeyondBio SCALE Overview
BeyondBio SCALE is a 9-month program dedicated to helping startups navigate the challenging journey from start-up to scale-up. An interdisciplinary team from AstraZeneca and their global partners - Accenture, AWS, Clalit Health Services will share world-class insights, expertise, resources, connections and guidance equipping your startup with the tools and business links to accelerate deployment at scale. BeyondBio SCALE program is part of AstraZeneca’s BeyondBio Innovation Hub activity in Israel and the A.Catalyst global Innovation hub network by AstraZeneca. BeyondBio vision is to improve healthcare by advancing cutting-edge science, technology, and innovation from Israel and reaching patients and healthcare systems around the globe.
Latest News
growth-positive
Six Israeli startups selected to participate in BeyondBio SCALE program | CTech
Six Israeli startups have been selected to participate in the BeyondBio SCALE program led by AstraZeneca, Accenture, Clalit, and AWS. The program aims to help startups in the fields of digital health and artificial intelligence scale up their solutions. The startups focus on improving cancer treatment, enabling efficient data sharing for research, and using AI to predict drug safety. The program partners will provide expert support and business skills to accelerate the startups growth. The program is expected to last until July 2023.
PartnersCustomers
growth-positive
AstraZeneca, Accenture, AWS and Clalit Health Services launch BeyondBio SCALE startup program | CTech
Pharmaceutical company AstraZeneca, consulting firm Accenture, Amazon Web Services, and Israeli health organization Clalit Health Services have launched a new startup program called BeyondBio SCALE. The program aims to enhance the growth of Israels digital health sector. It will assist startups to expand into markets with the help of program collaborators and their clinical, commercial, and technical expertise. The program is expected to start in November and run until next summer.
PartnersExpand
growth-positive
The digital health revolution: PlayBeyondBio's startup cohort comes to a close CTech
AstraZeneca, the JVP venture capital fund, Accenture, Margalit Startup City, Amazon Web Services (AWS), and Shaare Zedek Medical Center in Jerusalem have completed a six-month program aimed at promoting digital health. The program included eight startups selected from 100 candidates. These startups received individual guidance from the program’s partners, the opportunity to collaborate with international organizations, and to make connections with leading players in the global health systems. The startups included C2i Genomic, Nucle.ai, Itamar Medical, iBex, Octopus, Imagene, Cordio, and Medial Earlysign.
PartnersCustomersInvestment
growth-positive
מהפכה בבריאות דיגיטלית: סיום מחזור הסטארט-אפים במיזם PlayBeyondBio כלכליסט
A 6-month project involving 8 breakthrough startups in the field of digital health was led in partnership with AstraZeneca, venture capital fund JVP, international consulting firm Accenture, Margalit Startup City, Amazon Web Services, and Shaare Zedek Medical Center in Jerusalem. The program creates collaborations between startups and international pharmaceutical companies, investors, health institutions, and tech leaders. The startups selected for the program were chosen after a rigorous selection process that identified the need and opportunities in the field of medicine in the coming decade.
Partners
growth-positive
PlayBeyondBio names nine healthtech startups for mentoring and development program
The PlayBeyondBio initiative has selected nine startups to participate in its program for companies developing solutions for future healthcare challenges. The selected startups will receive fast-track assistance, focusing on commercialization agreements, implementation, and investments from the program’s partners. The selected startups include Itamar Medical, Medial Earlysign, and C2I Genomics, among others. The program aims to identify and promote mature, active companies with proven potential. The selected startups were revealed at a special event at the Margalit Startup City Center for Excellence in Jerusalem.
InvestmentPartners
Team Members
2
Web & Social Links
| Website | www.beyondbio.co.il/ |
Locations
Jerusalem, Israel
Photos & Videos
No files yet
BeyondBio SCALE Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Tags (10)
diagnosticshematologydigital-healthcaremetabolic-diseasecardiovascularoncologytherapeuticsrespiratoryinnovation-centerpharmaceuticalsBeyondBio SCALE Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
BeyondBio SCALE Lifecycle
BeyondBio SCALE News
11 articles
growth-positive
Six Israeli startups selected to participate in BeyondBio SCALE program | CTech
Six Israeli startups have been selected to participate in the BeyondBio SCALE program led by AstraZeneca, Accenture, Clalit, and AWS. The program aims to help startups in the fields of digital health and artificial intelligence scale up their solutions. The startups focus on improving cancer treatment, enabling efficient data sharing for research, and using AI to predict drug safety. The program partners will provide expert support and business skills to accelerate the startups growth. The program is expected to last until July 2023.
PartnersCustomers
growth-positive
AstraZeneca, Accenture, AWS and Clalit Health Services launch BeyondBio SCALE startup program | CTech
Pharmaceutical company AstraZeneca, consulting firm Accenture, Amazon Web Services, and Israeli health organization Clalit Health Services have launched a new startup program called BeyondBio SCALE. The program aims to enhance the growth of Israels digital health sector. It will assist startups to expand into markets with the help of program collaborators and their clinical, commercial, and technical expertise. The program is expected to start in November and run until next summer.
PartnersExpand
growth-positive
The digital health revolution: PlayBeyondBio's startup cohort comes to a close CTech
AstraZeneca, the JVP venture capital fund, Accenture, Margalit Startup City, Amazon Web Services (AWS), and Shaare Zedek Medical Center in Jerusalem have completed a six-month program aimed at promoting digital health. The program included eight startups selected from 100 candidates. These startups received individual guidance from the program’s partners, the opportunity to collaborate with international organizations, and to make connections with leading players in the global health systems. The startups included C2i Genomic, Nucle.ai, Itamar Medical, iBex, Octopus, Imagene, Cordio, and Medial Earlysign.
PartnersCustomersInvestment
growth-positive
מהפכה בבריאות דיגיטלית: סיום מחזור הסטארט-אפים במיזם PlayBeyondBio כלכליסט
A 6-month project involving 8 breakthrough startups in the field of digital health was led in partnership with AstraZeneca, venture capital fund JVP, international consulting firm Accenture, Margalit Startup City, Amazon Web Services, and Shaare Zedek Medical Center in Jerusalem. The program creates collaborations between startups and international pharmaceutical companies, investors, health institutions, and tech leaders. The startups selected for the program were chosen after a rigorous selection process that identified the need and opportunities in the field of medicine in the coming decade.
Partners
growth-positive
PlayBeyondBio names nine healthtech startups for mentoring and development program
The PlayBeyondBio initiative has selected nine startups to participate in its program for companies developing solutions for future healthcare challenges. The selected startups will receive fast-track assistance, focusing on commercialization agreements, implementation, and investments from the program’s partners. The selected startups include Itamar Medical, Medial Earlysign, and C2I Genomics, among others. The program aims to identify and promote mature, active companies with proven potential. The selected startups were revealed at a special event at the Margalit Startup City Center for Excellence in Jerusalem.
InvestmentPartners
growth-positive
PlayBeyondBio begins second cohort looking for health solutions in a post-Covid world
AstraZeneca, in collaboration with JVP, Accenture, and Margalit Startup City, is running the PlayBeyondBio initiative to identify startups developing technologies and tools for disease prediction and diagnosis. The initiative aims to select eight Israeli startups in the field of digital health to participate in mentorship programs, partnerships, and investments. The goal is to accelerate the commercialization of their products. The initiative was launched last year and expects to continue the efforts to leverage data and advanced analytics for disease detection and diagnosis. AstraZeneca Israel is investing in efforts to provide health systems with better tools, while Accenture Israel believes the partnership will lead to revolutionary medical solutions.
PartnersInvestment
growth-positive
PlayBeyondBio Program: Corona vaccine developer, AstraZeneca, selects two Israeli startups for investment
Two Israeli digital health startups will begin international pilots and new collaborations with the pharma giant AstraZeneca following their participation in the PlayBeyondBio program. The startups were selected from nine companies that participated in the project led by AstraZeneca, Jerusalem Venture Partners (JVP) Fund, and Margalit Startup City Community over the last six months. The PlayBeyondBio program aimed to transform Israeli startups in the field of digital health into groundbreaking international companies. The selected startups participated in a six-month fast track mentoring and development program. The startups selected for the international pilot by AstraZeneca are Docdok.health and TimeStamp. The program also involved strategic partners such as Microsoft, Cisco, Kahn-Sagol Maccabi Research Innovation Institute, and Jerusalem’s Sha’are Zedek Medical Center.
Partners
growth-positive
https://www.jpost.com/israel-news/jvp-pharma-giant-astrazeneca-mentor-israeli-health-start-ups-into-market-627852
Nine Israeli health tech start-ups have been selected to join the PlayBeyondBio program, a joint platform established by AstraZeneca and Jerusalem Venture Partners (JVP) to grow internationally disruptive digital health companies. The program aims to connect entrepreneurs, investors, and potential customers in collaboration with Maccabitech Healthcare Research and Innovation Institute, Morris Kahn, the Sagol Fund, Shaare Zedek Medical Center, and Microsoft for Startups. The selected start-ups will receive mentorship and guidance from AstraZeneca and JVP, with a focus on developing breakthrough technologies in various areas of healthcare. The program is expected to promote Israels standing as a global leader in digital health.
PartnersInvestment
growth-positive
JVP, British Pharma Firm AstraZeneca Launch Digital Health Platform
AstraZeneca and Jerusalem Venture Partners (JVP) have announced a joint initiative called PlayBeyondBio, aimed at promoting innovative startups in the digital health field. Ten startups will be selected to join the PlayBeyondBio business platform, which will provide mentorship, guidance, and access to resources to help accelerate their global market growth. The initiative is a collaboration with Israel Initiative 2020, Maccabitech Healthcare Research and Innovation Institute, Morris Kahn, the Sagol Fund, Shaare Tzedek Hospital, and Microsoft for Startups. AstraZeneca and JVP previously signed a cooperation agreement to invest in digital health in Israel, with the first investment estimated to be about NIS 10 million ($2.8 million). Applications for PlayBeyondBio will close on March 11, 2020.
PartnersInvestment
growth-positive
AstraZeneca looking for Israeli digital health cos
AstraZeneca has launched BeyondBio, a cooperation agreement in Israel for finding and investing in digital health companies. The company is partnering with Jerusalem Venture Partners (JVP), the Digital Israel National Initiative, the Qesem Center, and Kahn-Sagol-Maccabi Research and Innovation Institute. The goal is to support and assist startups in the digital health sector and provide access to digital health databases and research institutions in Israel. AstraZenecas chief commercial digital officer, Karan Arora, emphasizes the need to expand this activity and highlights the importance of developing products that improve patients lives. Arora discusses the potential of digital health products in predicting and preventing asthma attacks and heart attacks. He also mentions the value of gathering information to prove drug effectiveness and obtain insurance reimbursement. The article concludes with insights from a conference on digital health in Israel, where Arora made connections with local innovation networks.
PartnersInvestment
growth-positive
https://www.jpost.com/Jpost-Tech/JVP-AstraZeneca-agree-to-identify-develop-and-invest-in-digital-health-609193
AstraZeneca plc has signed a cooperation agreement with Jerusalem Venture Partners to identify, develop, and invest in digital health in Israel. The partnership, called BeyondBio, aims to develop and promote start-ups in the digital health field to address industry challenges. AstraZenecas first investment in Israel is estimated to be about NIS 10 million. The company will provide support to Israeli start-ups by granting them access to databases and academic research institutes. The partnership also involves other organizations such as the Israel National Initiative Association, Maccabitech Healthcare Research and Innovation Institute, Morris Kahn, and Microsoft Corporation. AstraZeneca has also partnered with the ARC Innovation Center at the Sheba Medical Center for research and development in Israels healthcare system.
PartnersInvestment
Alumni (19)
Curesponse
QuantHealth
C2i Genomics
Cordio Medical
Ibex Medical Analytics
Imagene
Itamar Medical
Medial EarlySign
Nucleai
Octopus.Health
BioT
Biobeat
DiA Imaging Analysis
Flask Data
IDEA Bio-Medical
ResMetrix Medical
Serenus.AI
TimeStamp
docdok.health
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
BeyondBio SCALE Internal
Recent Updates
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:47:49.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:50:10.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:49:52.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 13:00:33.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:50:10.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 13:00:43.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:51:10.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:49:52.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-02-28 09:32:42.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-02-28 09:32:59.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:49:41.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 13:00:43.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:52:32.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:59:49.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:48:14.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:49:41.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-01-10 06:24:04.000000
Zofia Mandefro
· zofia.mandefro@mail.huji.ac.il · Manual · 2023-01-10 12:47:07.000000
Zofia Mandefro
· zofia.mandefro@mail.huji.ac.il · Manual · 2023-01-10 12:47:07.000000
Lihi Hershkovitz
· lihi1306@gmail.com · Automatic · 2023-03-21 09:15:47.000000
Maor Perlov
· maor.perlov@sncentral.org · Manual · 2022-11-14 09:16:34.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:51:00.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-01-10 06:21:43.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 13:17:10.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-01-10 06:17:03.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:50:10.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-01-10 06:38:03.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:55:12.000000
Dana Arnon
· dana.arnon@mail.huji.ac.il · Manual · 2023-01-10 06:17:03.000000
Yanina Wainscheinker
· yanina.wainscheinker@sncentral.org · Manual · 2023-03-23 12:48:14.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 47/100 |
| Missing | funding stage, product stage, sector, number of employees, business model, tag line, funding rounds, markets, external profiles, not claimed |
| BI Verification | Jenny Sotnik-Talisman |
| Creator | Hilla Gorokhovsky |
| Creator email | hilla.gorokhovsky@sncentral.org |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-03-23T00:00:00.000Z |
| Created | 2020-02-18T00:00:00.000Z |